The judge cited Shkreli’s “particularly heartless and coercive” tactics in monopolizing Daraprim and keeping generic rivals ...

The U.S. Supreme Court declined on Monday to hear former pharmaceutical company CEO Martin Shkreli's challenge to a $64.6 ...

The Supreme Court on Monday rejected a bid by notorious "pharma bro" Martin Shkreli to hear his appeal of a $64 million ...

The justices turned away Shkreli's appeal of a lower court's decision upholding the penalty, equal to the profits he and one ...

The U.S. Supreme Court decided on Monday not to take up Martin Shkreli’s appeal of a $64.6 million penalty he received after ...

The U.S. Supreme Court declined on Monday to review former pharmaceutical executive Martin Shkreli's challenge to a $64 ...

The Supreme Court on Monday rejected an appeal from Martin Shkreli, who was once dubbed “Pharma Bro” after jacking up the ...

There were no generic alternatives to a lifesaving drug when Shkreli jacked up its price by more than $700 per pill in 2015.

In a significant legal development, the U.S. Supreme Court has denied Martin Shkreli’s appeal to overturn a $64.6 million ...

The former pharmaceutical executive sought to appeal a $64.6 million judgement issued against him for inflating drug cost and ...

The U.S. Supreme Court on Monday rejected appeals from two high-profile figures: R&B singer R. Kelly, and former pharmaceutical executive Martin Shkreli, known as "Pharma Bro." Kelly, who is serving a ...